Shots:

• J&J Vision reports the US FDA approval and launch of two post-market clinical trials to demonstrate the rotational stability and visual outcomes offered by the TECNIS Toric II platform- conducted at 50 sites across the US in 1000 patients
• The focus of the launch is to provide surgeons with a higher degree of confidence in treating astigmatism and to raise the standard of care for patients with cataracts
• TECNIS Toric II 1-Piece Intraocular Lens is the first IOL offered on the new TECNIS Toric II platform- featuring more surface texture and friction on the IOL haptics

Click here to­ read full press release/ article | Ref: JNJ | Image: PRNewswire